{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:50:10Z","timestamp":1782420610507,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pcl.2026.02.008","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:02:50Z","timestamp":1775851370000},"page":"741-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Prescription Therapies for Warts and Molluscum"],"prefix":"10.1016","volume":"73","author":[{"given":"Courtney","family":"Heron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla","family":"Jahnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pcl.2026.02.008_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaad.2016.02.1219","article-title":"Dermatology-related outpatient visits by children: implications for workforce and pediatric education","volume":"75","author":"Prindaville","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2026.02.008_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdin.2025.02.004","article-title":"Duration of persistence of molluscum contagiosum: a retrospective study","volume":"21","author":"Yi","year":"2025","journal-title":"JAAD Int"},{"issue":"3","key":"10.1016\/j.pcl.2026.02.008_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/pde.12504","article-title":"Molluscum contagiosum: to treat or not to treat? Experience with 170 children in an outpatient clinic setting in the northeastern United States","volume":"32","author":"Basdag","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.pcl.2026.02.008_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1370\/afm.1508","article-title":"Natural course of cutaneous warts among primary schoolchildren: a prospective cohort study","volume":"11","author":"Bruggink","year":"2013","journal-title":"Ann Fam Med"},{"issue":"4","key":"10.1016\/j.pcl.2026.02.008_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1525-1470.2012.01810.x","article-title":"Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial","volume":"31","author":"Coloe","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"12","key":"10.1016\/j.pcl.2026.02.008_bib6","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jamadermatol.2020.3238","article-title":"Safety and efficacy of VP-102, a proprietary, drug-device combination product containing cantharidin, 0.7% (w\/v), in children and adults with molluscum contagiosum: two phase 3 randomized clinical trials","volume":"156","author":"Eichenfield","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.pcl.2026.02.008_bib7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/ijd.14079","article-title":"Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial","volume":"57","author":"Guzman","year":"2018","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.pcl.2026.02.008_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s40257-018-0375-4","article-title":"Efficacy and safety of topical cantharidin treatment for molluscum contagiosum and warts: a systematic review","volume":"19","author":"Vakharia","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.pcl.2026.02.008_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1067\/mjd.2000.106370","article-title":"Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients","volume":"43","author":"Silverberg","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.pcl.2026.02.008_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/0009922808326085","article-title":"Parental satisfaction, efficacy, and adverse events in 54 patients treated with cantharidin for molluscum contagiosum infection","volume":"48","author":"Cathcart","year":"2009","journal-title":"Clin Pediatr"},{"issue":"4","key":"10.1016\/j.pcl.2026.02.008_bib11","first-page":"878","article-title":"Comparative study of 10% potassium hydroxide and 0.05% tretinoin in treatment of molluscum contagiosum in children: 10% KOH and 0.05% trenoin in pediatric Molluscum treatment","volume":"34","author":"Ruvva","year":"2024","journal-title":"J Pak Assoc Dermatol"},{"issue":"5","key":"10.1016\/j.pcl.2026.02.008_bib12","article-title":"Interventions for cutaneous molluscum contagiosum","volume":"5","author":"van der Wouden","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 66","key":"10.1016\/j.pcl.2026.02.008_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.0366-077X.2003.05631.x","article-title":"Experience in treating molluscum contagiosum in children with imiquimod 5% cream","volume":"149","author":"Bayerl","year":"2003","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.pcl.2026.02.008_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/idoj.idoj_259_24","article-title":"Berdazimer sodium: a novel nitric oxide-releasing drug in dermatology","volume":"16","author":"Palaniappan","year":"2025","journal-title":"Indian Dermatol Online J"},{"issue":"6","key":"10.1016\/j.pcl.2026.02.008_bib15","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/pde.15419","article-title":"Safety and efficacy of topical nitric oxide-releasing berdazimer gel for molluscum contagiosum clearance: a systematic review and meta-analysis of randomized controlled trials","volume":"40","author":"Pera Calvi","year":"2023","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.pcl.2026.02.008_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archderm.1958.01560050014003","article-title":"Treatment of warts with cantharidin","volume":"77","author":"Epstein","year":"1958","journal-title":"AMA Archives of Dermatology"},{"issue":"6","key":"10.1016\/j.pcl.2026.02.008_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13143","article-title":"Real-life treatment of cutaneous warts with cantharidin podophyllin salicylic acid solution","volume":"32","author":"Nguyen","year":"2019","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.pcl.2026.02.008_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/09546639609086864","article-title":"Evaluation of the efficacy and safety of 0.05% tretinoin cream in the treatment of plane warts in Arab children","volume":"7","author":"Kubeyinje","year":"1996","journal-title":"J Dermatol Treat"},{"issue":"3","key":"10.1016\/j.pcl.2026.02.008_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1525-1470.2002.00083.x","article-title":"Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children","volume":"19","author":"Grussendorf-Conen","year":"2002","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.pcl.2026.02.008_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1525-1470.2008.00800.x","article-title":"5% 5-Fluorouracil cream for treatment of verruca vulgaris in children","volume":"26","author":"Gladsjo","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.pcl.2026.02.008_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00024669-200302030-00001","article-title":"New approaches to the treatment of actinic keratosis","volume":"2","author":"Jeffes","year":"2003","journal-title":"Am J Cancer"},{"issue":"12","key":"10.1016\/j.pcl.2026.02.008_bib22","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1468-3083.2010.03961.x","article-title":"Topical cidofovir for viral warts in children","volume":"25","author":"Fern\u00e1ndez-Morano","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.pcl.2026.02.008_bib23","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s13555-022-00818-7","article-title":"Use of contact immunotherapy in the treatment of skin diseases other than alopecia areata","volume":"12","author":"Lai","year":"2022","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.pcl.2026.02.008_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1525-1470.2000.01762.x","article-title":"Use of squaric acid dibutylester (SADBE) for cutaneous warts in children","volume":"17","author":"Micali","year":"2000","journal-title":"Pediatr Dermatol"},{"issue":"9","key":"10.1016\/j.pcl.2026.02.008_bib25","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jdcr.2018.07.003","article-title":"Anaphylaxis to diphenylcyclopropenone during sensitization for wart treatment\u2014A case report","volume":"4","author":"Venkatesh","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.pcl.2026.02.008_bib26","article-title":"Treatment of warts in pediatrics: a review","volume":"6","author":"Pope","year":"2020","journal-title":"Journal of Family Medicine and Disease Prevention"},{"issue":"13","key":"10.1016\/j.pcl.2026.02.008_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12134230","article-title":"Treatment of pediatric anogenital warts in the era of HPV-Vaccine: a literature review","volume":"12","author":"Herzum","year":"2023","journal-title":"J Clin Med"},{"issue":"7362","key":"10.1016\/j.pcl.2026.02.008_bib28","first-page":"461","article-title":"Local treatments for cutaneous warts: systematic review","volume":"325","author":"Gibbs","year":"2002","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.pcl.2026.02.008_bib30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.47102\/annals-acadmedsg.2020342","article-title":"The quadrivalent human papillomavirus vaccine in recalcitrant non-genital warts: a retrospective study","volume":"49","author":"Kuan","year":"2020","journal-title":"Ann Acad Med Singapore"},{"issue":"41","key":"10.1016\/j.pcl.2026.02.008_bib31","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1016\/j.vaccine.2014.07.014","article-title":"Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes","volume":"32","author":"Barzon","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.pcl.2026.02.008_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09546634.2018.1527006","article-title":"Quadrivalent human papilloma virus vaccine for the treatment of multiple warts: a retrospective analysis of 30 patients","volume":"30","author":"Yang","year":"2019","journal-title":"J Dermatol Treat"},{"issue":"2","key":"10.1016\/j.pcl.2026.02.008_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D33S15Q645","article-title":"Cimetidine: a review of the recent developments and reports in cutaneous medicine","volume":"9","author":"Scheinfeld","year":"2003","journal-title":"Dermatol Online J"},{"issue":"10","key":"10.1016\/j.pcl.2026.02.008_bib34","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archderm.137.10.1357","article-title":"Cantharidin revisited: a blistering defense of an ancient medicine","volume":"137","author":"Moed","year":"2001","journal-title":"Arch Dermatol"},{"issue":"8 Suppl 1","key":"10.1016\/j.pcl.2026.02.008_bib36","first-page":"S4","article-title":"Mollusntcum coagiosum: epidemiology, considerations, treatment options, and therapeutic gaps","volume":"16","author":"Hebert","year":"2023","journal-title":"J Clin Aesthet Dermatol"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395526000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395526000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:41:29Z","timestamp":1782420089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395526000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0031395526000167"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2026.02.008","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Prescription Therapies for Warts and Molluscum","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2026.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}